Skip Navigation

European Journal of Echocardiography 2005 6(4):235-237; doi:10.1016/j.euje.2005.05.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Eur J Echocardiogr
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hayat, S. A.
Right arrow Articles by Senior, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayat, S. A.
Right arrow Articles by Senior, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, The European Society of Cardiology

Safety: The heart of the matter

Sajad A. Hayat and Roxy Senior*

Department of Cardiology, Northwick Park Hospital, St. Mark's NHS Trust, Cardiac Research Department, Watford Road, Harrow, Middlesex HA1 3UJ, UK

Received 30 April 2005; accepted after revision 1 May 2005.

* Corresponding author. Tel.: +44 208 869 2547; fax: +44 208 864 0075. E-mail: roxy.senior@virgin.net


  Abstract

An integral part of evaluation of cardiac disease in modern day medicine is echocardiography. It has made great strides since the initial collaboration of Dr Helmut Hertz and Dr Inge Edler. In its modern day form, echocardiography maintains a legacy of a bedside utility while adopting many of the technologic advances ushered in by the digital era. As a result, it boasts a broad and growing spectrum of application including routine use in primary cardiac diagnosis and screening, therapeutic assessment, and guidance of interventional and surgical procedures. With the advent of ultrasound contrast agents it is now arguably the most complete ‘one-stop’ investigational tool to assess cardiac structure, function and perfusion. However, has it maintained its safety profile? The familiar and oft quoted dictum in medicine of "first do no harm" is of great importance for any diagnostic tool and patient safety should remain a primary consideration for any new investigational technique. In this issue Cosyns' et al. have examined whether some of the theoretical and in vitro experimental concerns surrounding myocardial injury during and following contrast echocardiography result in any detectable change in cardiac function.

Keywords: Myocardial contrast echocardiography; Safety; Ultrasound contrast agents; Tissue Doppler; Inertial cavitation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Eur J Echocardiogr:

Tissue Doppler imaging does not show infraclinical alteration of myocardial function after contrast echocardiography
Bernard Cosyns, Caroline Weytjens, Marc Vanderhoogstrate, Cathy Daniels, Danny Schoors, and Guy Van Camp
Eur J Echocardiogr 2005 6: 238-242. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
D. Vancraeynest, J. Kefer, C. Hanet, C. Fillee, C. Beauloye, A. Pasquet, B. L. Gerber, M. Philippe, and J.-L. J. Vanoverschelde
Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans
Eur. Heart J., May 2, 2007; 28(10): 1236 - 1241.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.